GRCE GRACE THERAPEUTICS INC US FDA Inspections 8-K Filing 2023 - Approval Acasti Pharma Inc. has announced their alignment with the U.S. Food and Drug Administration's protocol for their phase 3 safety trial of GTX-104.Get access to all SEC 8-K filings of the GRACE THERAPEUTICS INC